Will Short Term Positive News Increase The Share Price Of Penn Virginia Corporation (PVAC)?

Penn Virginia Corporation (PVAC) has seen some recent movement in the stock market and its common shares closed at $9.22 yesterday. Traders are starting to take interest of PVAC as the common shares traded as high as $9.94 and as low as $9.22 in the prior market session.

Penn Virginia Corporation (PVAC) average trading volume is 706.12K. However, in the prior market session Penn Virginia Corporation (PVAC) exchanged 418,707 shares. The 1st support level on PVAC is $8.99 and the 1st upside resistance level on PVAC is $17.66. PVAC 50day moving average is $9.89 and PVAC two hundred day moving average is $9.34.

Penn Virginia Corporation (PVAC) recent performance has been specified by the recent movement in PVAC common shares. PVAC has performed -10.92% over the past 4 weeks, PVAC has performed -17.57% over the past 3 months and PVAC has shown -64.94% over the past year. Penn Virginia Corporation (PVAC) has a 52 week range of $0.99 to $32.30. Penn Virginia Corporation (PVAC) is trading 831.31% from its 52 week low and -71.46% from its 52 week high. Penn Virginia Corporation (PVAC) is showing a 15.26% short float showing the amount short in the float.

PVAC has 15.17M shares outstanding and 14.97M shares in the float. Penn Virginia Corporation (PVAC) presently has a market cap of $146.23M and income of 126.00M. The EPS next quarter for PVAC is 0.95 and anticipated EPS next year is -85.39%. The market cap of Penn Virginia Corporation (PVAC) at $146.23M represents how many Traders own shares of PVAC and is based off the last price ($9.22) of PVAC and the amount of shares outstanding (15.17M) with Penn Virginia Corporation (PVAC).

Penn Virginia Corporation (PVAC) has aggregate cash (mrq) of 21.95M, aggregate cash per share (mrq) of 1.45, aggregate debt of PVAC is at 563.45M and aggregate debt/equity (mrq) is 95.41. . Penn Virginia Corporation (PVAC) operational cash flow (ttm) is 294.73M, PVAC leveraged free cash flow (ttm) is -118.34M.

PVAC is trading -5.95% below (bearish) its SMA20, -13.83% below (bearish) its SMA50 and -19.33% below (bearish) its SMA200.

Related Articles

Dada Group (NASDAQ: DADA) Extends Partnership With Lianhua Supermarket

Dada Group (NASDAQ: DADA) has disclosed that it has extended its strategic partnership with Lianhua Supermarket Holdings Co., Ltd. Both the companies aimed to focus...

Diana Shipping (NYSE: DSX) Signs Time Charter Contract With CLdN Cobelfret

Diana Shipping (NYSE: DSX) has revealed that it has signed a time charter contract with CLdN Cobelfret SA through its fully-owned unit. US$12,100 is...

Biogen (NASDAQ: BIIB) And Sage Therapeutics Inks Agreement To Develop Therapies For Depression

Biogen Inc. (NASDAQ: BIIB) and Sage Therapeutics, Inc. (NASDAQ: SAGE) communicated that they are partnering together and will be combining their efforts to develop...

Get in Touch

19,000FansLike
35,222FollowersFollow
22,458FollowersFollow

Latest Posts

Dada Group (NASDAQ: DADA) Extends Partnership With Lianhua Supermarket

Dada Group (NASDAQ: DADA) has disclosed that it has extended its strategic partnership with Lianhua Supermarket Holdings Co., Ltd. Both the companies aimed to focus...

Diana Shipping (NYSE: DSX) Signs Time Charter Contract With CLdN Cobelfret

Diana Shipping (NYSE: DSX) has revealed that it has signed a time charter contract with CLdN Cobelfret SA through its fully-owned unit. US$12,100 is...

Biogen (NASDAQ: BIIB) And Sage Therapeutics Inks Agreement To Develop Therapies For Depression

Biogen Inc. (NASDAQ: BIIB) and Sage Therapeutics, Inc. (NASDAQ: SAGE) communicated that they are partnering together and will be combining their efforts to develop...

BBVA And Sabadell Ends Talks Of A Merger Due To Conflict Over Price

Banco Bilbao Vizcaya Argentaria S.A. (NYSE: BBVA) and Banco de Sabadell SA have discussed the terms of a merger but the negotiation turned out...

Hancock Jaffe (NASDAQ: HJLI) Confirms 1:25 Reverse Stock Split

Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI), a company that manufactures medical devices used to treat heart problems, publicized that its Board of Directors has...